North America Realizing Robust Capital Spending For Biologics Manufacturing Facilities, an Industrial Info Market Brief

Biologics are products that are produced from living organisms or contain components of living organisms. Examples include vaccines, plasmas, cell/gene therapies, active pharmaceutical ingredients (APIs) and antigens. Manufacturing firms such as Merck, CSL Behring, Pfizer, Sanofi Pasteur and Gilead/Kite are continuing to heavily invest in their North American manufacturing facilities. Industrial Info is tracking 179 major capital projects in this sector in the U.S. and Canada with a total investment value of about $11 billion.